Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Background:
Liver transplantation is the only curative treatment for patients with end-stage liver disease. Short-term survival has improved due to improved surgical techniques and greater efficacy of immunosuppressive drugs. At present, the 10-year survival after liver transplantation is 60%, but long-term survival has not improved to the same extent the short-term survival. In addition to liver- and transplant-related causes, comorbidities such as cardiovascular, pulmonary, renal, and metabolic diseases have emerged as leading causes of morbidity and mortality in liver transplant recipients.
The objective of this study is to assess the burden of comorbidities and identify both liver- and transplant-related risk factors as well as traditional risk factors that contribute to the pathogenesis of comorbidity in liver transplant recipients.
Methods/design:
The DACOLT study is an observational, longitudinal study. The investigators aim to include all adult liver transplant recipients in Denmark. Participants will be matched by sex and age to controls from the Copenhagen General Population Study (CGPS) and the Copenhagen City Heart Study (CCHS). Physical and biological measures including blood pressure, ancle-brachial index, spirometry, exhaled nitric oxide, electrocardiogram, transthoracic echocardiography, computed tomography (CT) angiography of the heart, unenhanced CT of chest and abdomen and blood samples will be collected using uniform protocols in participants in CGPS, CCHS and DACOLT. Blood samples will be collected and stored in a research biobank. Follow-up examinations at regular intervals up to 10 years of follow-up are planned.
Discussion:
There is no international consensus standard for optimal clinical care or monitoring of liver transplant recipients. The study will determine prevalence, incidence and risk factors for comorbidity in liver transplant recipients and may be used to provide evidence for guidelines on screening and long-term treatment and thereby contribute to improvement of the long-term survival.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Liver transplant recipients | All liver transplant recipient in Denmark aged 20-100 years will be eligible for inclusion in the DACOLT study. Inclusion requires the individual to be able to understand the study information in either Danish or English and to be able to provide an informed consent. | ||
| Control group 1_CGPS | The Copenhagen General Population Study (CGPS) is an ongoing observational population study with more than 110.000 participants from the greater Copenhagen area. All residents in the greater Copenhagen area > 40 years and 25% of 20-40 years old are invited to participate in the study and in follow-up examinations every decade. A random sample of 10.000 participants aged ≥ 40 years had a contrast enhanced CT of the chest including CT angiography of the heart performed. Of these, 6500 had a contrast enhanced CT of the abdomen. | ||
| Control group 1_CCHS | The Copenhagen City Heart Study (CCHS) includes a random population sample included from the greater Copenhagen area. Health surveys have been repeated 5 times between 1976 and 2015. Almost 4000 participants were randomly selected for echocardiography. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence of coronary artery disease | Assessed by coronary CT angiography | Baseline cross-sectional data |
| Change in Coronary artery disease | Assessed by coronary CT angiography | 10 years follow-up |
| Cardiac function | Determined by transthoracic echocardiography | Baseline cross-sectional data |
| Change in Cardiac function | Determined by transthoracic echocardiography | 10 years follow-up |
| Cardiac structure | Determined by transthoracic echocardiography | Baseline cross-sectional data |
| Change in cardiac structure | Determined by transthoracic echocardiography | 10 years follow-up |
| Cardiac structure | Assessed by cardiac computed tomography (CT) | Baseline cross-sectional data |
| Change in Cardiac structure | Assessed by cardiac computed tomography (CT) | 10 years follow-up |
| Cardiac function |
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence of Depression | Major Depression Inventory (MDI): A depression questionnaire. The questionnaire consists of the ten symptoms contained in the World Health Organization WHO's depression demarcation. The patient's completed questionnaire is scored using a scoring key. When MDI is used as a rating scale in the same way as the Hamilton scales, then the sum of the ten questions indicates the degree of depression. The theoretical score range is from 0 (no depression) to 50 (maximum depression). Mild depression: MDI total score from 21 to 25 Moderate depression: MDI total score from 26 to 30 Severe depression: MDI total score of 31 or higher |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
All liver transplanted individuals in Danmark.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Susanne D Rasmussen, Professor, MD, DMSc | Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet | Principal Investigator |
| Allan Rasmussen, MD | Department of Transplantation and Digestive Diseases, Copenhagen University Hospital - Rigshospitalet | Study Director |
| Klaus F Kofoed, Professor, MD, PhD, DMSc | Department of Cardiology, Copenhagen University Hospital - Rigshospitalet | Study Director |
| Tor Biering-Sørensen, Professor, MD, MSc, PhD | Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aalborg University Hospital | Aalborg | Denmark | ||||
| Aarhus University Hospital |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 42119773 | Derived | Suarez-Zdunek MA, Bock A, Schultz NA, Kuhl JT, Villadsen GE, Fialla AD, Hansen JB, Krohn PS, Emde KU, Kirkby NS, Kober L, Knudsen AD, Kofoed KF, Nielsen SD. Cytomegalovirus infection and coronary artery disease in liver transplant recipients: Nationwide study using protocolized cardiac computed tomography. Int J Infect Dis. 2026 Aug;169:108785. doi: 10.1016/j.ijid.2026.108785. Epub 2026 May 12. | |
| 41778959 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Biochemical analyses including fasting insulin and fasting blood glucose. Blood will be collected for a research biobank, and peripheral blood mononuclear cells, serum and plasma will be stored for further analyses of inflammation markers (chemokines, cytokines, soluble surface markers), coagulation markers (standard and functional platelet aggregation test), simulation assays and flowcytometry of PBMC, endothelial function markers (asymmetric dimethylarginine (ADMA), syndecan-1, trombomodulin and sE-selectin), markers of microbial translocation and bacterial degradation (sCD14, lipopolysaccharide, trimethylamine N-oxide), markers of lung tissue (alpha-1-antitrypsine, endothelin-1), liver markers (hyaluronic acid and fibrosis markers) and metabolomics and multiomics.
Assessed by cardiac computed tomography (CT) |
| Baseline cross-sectional data |
| Change in Cardiac function | Assessed by cardiac computed tomography (CT) | 10 years follow-up |
| Dynamic lung function indices assessed by spirometry | FVC and FEV1 assessed by spirometry | Baseline cross-sectional data |
| Change in Dynamic lung function indices assessed by spirometry | FVC and FEV1 assessed by spirometry | 10 years follow-up |
| Renal function | Estimated glomerular filtration rate | Baseline cross-sectional data |
| Change in Renal function | Estimated glomerular filtration rate | 10 years follow-up |
| Metabolic diseases | Prevalence of Diabetes | Baseline cross-sectional data |
| Metabolic diseases | Change in Diabetes | 10 years follow-up |
| Metabolic diseases | Prevalence of Dyslipidaemia | Baseline cross-sectional data |
| Metabolic diseases | Change in Dyslipidaemia | 10 years follow-up |
| Baseline cross sectional data |
| Change in Depression | Major Depression Inventory (MDI): A depression questionnaire. The questionnaire consists of the ten symptoms contained in the World Health Organization WHO's depression demarcation. The patient's completed questionnaire is scored using a scoring key. When MDI is used as a rating scale in the same way as the Hamilton scales, then the sum of the ten questions indicates the degree of depression. The theoretical score range is from 0 (no depression) to 50 (maximum depression). Mild depression: MDI total score from 21 to 25 Moderate depression: MDI total score from 26 to 30 Severe depression: MDI total score of 31 or higher | 10 years follow-up |
| Fracture risk | FRAX® score. The FRAX® tool has been developed to evaluate fracture risk of patients. It is based on individual patient models that integrate the risks associated with clinical risk factors. The FRAX® algorithms give the 10-year probability of fracture. The output is a 10-year probability of hip fracture and the 10-year probability of a major osteoporotic fracture (clinical spine, forearm, hip or shoulder fracture). | Baseline cross sectional data |
| Change in Fracture risk | FRAX® score. The FRAX® tool has been developed to evaluate fracture risk of patients. It is based on individual patient models that integrate the risks associated with clinical risk factors. The FRAX® algorithms give the 10-year probability of fracture. The output is a 10-year probability of hip fracture and the 10-year probability of a major osteoporotic fracture (clinical spine, forearm, hip or shoulder fracture). | 10 year follow-up |
| Obstructive pulmonary disease | Nitric oxide in exhaled breath | Baseline cross sectional data |
| Obstructive pulmonary disease | Change in Nitric oxide in exhaled breath | 10 year follow-up |
| Prevalence of Peripheral artery disease | Ankle-brachial-index (ABI) is measured using a Doppler meter by determining the systolic pressure in the arm and ankle. | Baseline cross sectional data |
| Change in Peripheral artery disease | Ankle-brachial-index (ABI) is measured using a Doppler meter by determining the systolic pressure in the arm and ankle. | 10 years follow-up |
| Aarhus |
| Denmark |
| Copenhagen University Hospital - Rigshospitalet | Copenhagen | 2100 | Denmark |
| Odense University Hospital | Odense | Denmark |
| Derived |
| Knudsen AD, Kuhl JT, Schultz NA, Villadsen GE, Hogh J, Arentoft N, Suarez-Zdunek MA, Bock A, Fialla AD, Hansen JB, Krohn PS, Nordestgaard BG, Kober LV, Larsen AF, Pham MHC, Sigvardsen PE, Afzal S, Kofoed KF, Rasmussen A, Nielsen SD. Coronary Atherosclerosis in Liver Transplant Recipients and Population Controls: A Nationwide Study Using Protocolized CT Angiography. J Am Coll Cardiol. 2026 Jun 9;87(22):3077-3092. doi: 10.1016/j.jacc.2026.01.041. Epub 2026 Mar 4. |
| 38570629 | Derived | Suarez-Zdunek MA, Arentoft NS, Krohn PS, Lauridsen EHE, Afzal S, Hogh J, Thomsen MT, Knudsen AD, Nordestgaard BG, Hillingso JG, Villadsen GE, Holland-Fischer P, Rasmussen A, Fialla AD, Feldt-Rasmussen U, Nielsen SD. Prevalence of hyperthyroidism and hypothyroidism in liver transplant recipients and associated risk factors. Sci Rep. 2024 Apr 3;14(1):7828. doi: 10.1038/s41598-024-58544-3. |
| 33794793 | Derived | Thomsen MT, Hogh J, Knudsen AD, Jensen AMR, Gelpi M, Villadsen GE, Abazi R, Holland-Fischer P, Kober L, Clemmesen O, Krohn PS, Hillingso J, Vilsboll T, Biering-Sorensen T, Kofoed KF, Nordestgaard BG, Rasmussen A, Nielsen SD. The Danish comorbidity in liver transplant recipients study (DACOLT): a non-interventional prospective observational cohort study. BMC Gastroenterol. 2021 Apr 1;21(1):145. doi: 10.1186/s12876-021-01733-5. |